Complete HEOR Solutions (CHEORS) Revenue and Competitors

North Wales, USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Complete HEOR Solutions (CHEORS)'s estimated annual revenue is currently $18.7M per year.(i)
  • Complete HEOR Solutions (CHEORS)'s estimated revenue per employee is $201,000

Employee Data

  • Complete HEOR Solutions (CHEORS) has 93 Employees.(i)
  • Complete HEOR Solutions (CHEORS) grew their employee count by 0% last year.

Complete HEOR Solutions (CHEORS)'s People

NameTitleEmail/Phone
1
VP, Evidence GenerationReveal Email/Phone
2
VP, Economic ModelingReveal Email/Phone
3
DirectorReveal Email/Phone
4
Director Business Development & SalesReveal Email/Phone
5
Senior HEOR Manager, ConsultantReveal Email/Phone
6
Senior Manager, Health Economics and Outcome ResearchReveal Email/Phone
7
Associate ManagerReveal Email/Phone
8
Associate ManagerReveal Email/Phone
9
ManagerReveal Email/Phone
10
ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is Complete HEOR Solutions (CHEORS)?

CHEORS provides cutting-edge health economic insights emphasizing a wholistic approach towards HEOR. We provide best-in-class HEOR services including economic modeling, country adaptations of the economic models for HTA submissions, systematic literature review, meta-analysis, and database analysis. In addition, we assist pharmaceutical companies with market-access planning and offer support to payers with modifying economic models and evaluating value-based contracts.

keywords:N/A

N/A

Total Funding

93

Number of Employees

$18.7M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$25M1027%N/A
#2
$21.8M1043%$154.4M
#3
$31.6M1096%N/A
#4
$29.6M1242%N/A
#5
$24.8M13810%N/A